Medical Science Liaison - Midwest

Pharvarisis a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to potentially address all types of bradykinin-mediated angioedema. By targeting this clinically proven therapeutic target with novel, oral small molecules, the Pharvaris team is advancing new alternatives to injected therapies for the prevention and treatment of hereditary angioedema (HAE) attacks, and other bradykinin B2-receptor-mediated indications. HAE is a rare and potentially life-threatening genetic disease and people living with HAE can suffer sudden and prolonged attacks of swelling in multiple areas of the body, including the airway, which can be life-threatening.

We are expanding our U.S. Medical Affairs team and are looking for a Medical Science Liaison to join our team and report to our Head of MSLs North America.

We have a culture built on the core values of considering others carefully, leading with trust, ensuring rigor and diversity of thought, and contributing freely.

Our company is driven by individuals committed to developing breakthrough therapies which can have a real impact on people’s lives. If you are looking for a place where your work can have meaning, and you can make a difference – Pharvaris is the place for you!

This is a field based medical affairs role.

• Serve as the field-based extension of the Pharvaris’ Medical Affairs Team
• Field-based activities expected to comprise >80% of MSL responsibilities.
• Systematically identify the scientific exchange needs of Key Opinion Leaders (KOLs), investigators and other stakeholders in patient care, establish strong professional relationships, provide credible scientific expertise and serve as a liaison to Pharvaris North America’s Medical, Clinical Development/Operations and external partners.
• Ensure compliant communication and education of Pharvaris’ product portfolio to meet the educational and professional needs of Pharvaris’ key customers.
• Responds effectively to requests for scientific exchange.
• Support design and implementation of scientific programs with external experts and Global Medical Affairs.
• Support local team disease area and product knowledge through scientific training.
• Maintain personal expertise in relevant disease areas and MSL best practices.

• Through appropriate scientific exchange, builds and maintains professional relationship with external stakeholders to expand Pharvaris’ research, advisory and educational partnership opportunities.
• Ensures high standard of professionalism to develop and maintain “peer-to-peer” scientific relationships with key thought leaders in healthcare, academia, payer, and government organizations per strategic territory plans and as requested by KOLs/HCPs, including the management of strategic scientific partnerships and scientific exchange.
• Provide scientific liaison support to Investigators currently involved in Pharvaris’ interventional or observational studies and investigator-sponsored research.
• Provide scientific exchange and appropriate support to payer organizations.
• Serve as a liaison between HCPs and Pharvaris medical affairs.
• Facilitate 1:1 and group scientific interactions with healthcare professionals.
• Participate in KOL/HCP planning.
• Maintain KOL/HCP plans and update medical customer relationship management system in a timely, accurate and compliant manner.
• Maintain awareness of and access to internal and external information sources available to support high-quality scientific exchange, and coordinate high-quality interactions between these resources and external customers.

• Respond within defined timeline and quality standards to unsolicited inquiries from HCPs and other stakeholders received by Medical Affairs and referred to Global Medical Affairs by other Pharvaris functions, forwards reports of adverse events according to Pharvaris’ policy.
• Support development of appropriate responses to unique inquiries as required, such as the presentation of scientific evidence and medical education.
• Presents clinical and disease state information to a variety of audiences, including…